Form 8-K · Current report
M&T Bank 8-K, filed Sep 14, 2026
- Filed
- CIK
- 0000036270
- Accession no.
- 0000036270-26-000052
Summary
M&T Bank posted a third-quarter 2026 investor presentation to its website and filed it with the SEC under Regulation FD. The presentation reports first-half 2026 diluted earnings per share of $9.44, net income of $1,482 million, a 1.46% return on tangible assets and a 16.5% return on tangible common equity, along with a 10.19% CET1 capital ratio at the end of the second quarter of 2026.
Key points
- First-half 2026 diluted EPS was $9.44, up 25% year over year, and net income was $1,482 million, up 14%.
- Net interest margin was 3.70% and the efficiency ratio 55.5% in the first half of 2026.
- CET1 capital ratio fell to 10.19% at the end of 2Q26, with M&T expecting a 10.0% to 10.5% CET1 ratio in 2026.
- M&T says the 2026 stress test results would imply a reduction of its stress capital buffer to the 2.5% minimum.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01. Regulation FD Disclosure. On September 14, 2026, M&T Bank Corporation (“M&T”) posted an investor presentation to its website. A copy of the presentation is attached as Exhibit 99.1 hereto. From time to time, M&T may use this presentation in conversations with investors and analysts. The presentation can be found on the Investor Relations page of M&T’s website at ir.mtb.com/events-presentations. The information in this Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall it be deemed incorporated by…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.